We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$1.16B
AUM Growth
+$165M
Cap. Flow
+$61M
Cap. Flow %
5.24%
Top 10 Hldgs %
34.27%
Holding
2,827
New
142
Increased
1,379
Reduced
881
Closed
136

Sector Composition

Rank Sector Weight
1 Technology 15.25%
2 Financials 7.74%
3 Healthcare 7.09%
4 Consumer Discretionary 6.41%
5 Consumer Staples 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTN icon
1901
Gray Television
GTN
$430M
$16.1K ﹤0.01%
1,794
+1,183
+194% +$8.81K
AKR icon
1902
Acadia Realty Trust
AKR
$2.96B
$16.1K ﹤0.01%
946
+80
+9% +$1.2K
SNDR icon
1903
Schneider National
SNDR
$6.34B
$16.1K ﹤0.01%
631
AVNT icon
1904
Avient
AVNT
$3.41B
$16K ﹤0.01%
386
+33
+9% +$1.15K
XRX icon
1905
Xerox
XRX
$360M
$16K ﹤0.01%
872
-1,121
-56% -$16.6K
WWW icon
1906
Wolverine World Wide
WWW
$1.71B
$15.9K ﹤0.01%
1,792
+989
+123% +$8.41K
NRIM icon
1907
Northrim BanCorp
NRIM
$600M
$15.8K ﹤0.01%
1,104
HRI icon
1908
Herc Holdings
HRI
$4.95B
$15.8K ﹤0.01%
106
-4
-4% -$490
SKT icon
1909
Tanger
SKT
$4.84B
$15.7K ﹤0.01%
567
+278
+96% +$6.92K
SEM
1910
DELISTED
Select Medical
SEM
$15.7K ﹤0.01%
1,236
-1,869
-60% -$23.6K
ADAM
1911
Adamas Trust
ADAM
$783M
$15.6K ﹤0.01%
1,831
-584
-24% -$4.92K
WAL icon
1912
Western Alliance Bancorporation
WAL
$9.13B
$15.6K ﹤0.01%
237
+3
+1% +$151
TEVA icon
1913
Teva Pharmaceuticals
TEVA
$36.9B
$15.6K ﹤0.01%
1,493
-866
-37% -$8.09K
ESRT icon
1914
Empire State Realty Trust
ESRT
$976M
$15.4K ﹤0.01%
1,592
+1,233
+343% +$10.7K
CXT icon
1915
Crane NXT
CXT
$3.14B
$15.4K ﹤0.01%
271
AIR icon
1916
AAR Corp
AIR
$5.62B
$15.4K ﹤0.01%
246
RARE icon
1917
Ultragenyx Pharmaceutical
RARE
$2.56B
$15.2K ﹤0.01%
317
-94
-23% -$3.64K
NPKI
1918
NPK International
NPKI
$1.09B
$15.1K ﹤0.01%
2,281
PFF icon
1919
iShares Preferred and Income Securities ETF
PFF
$13.2B
$15K ﹤0.01%
481
-4,769
-91% -$142K
PFBC icon
1920
Preferred Bank
PFBC
$1.25B
$15K ﹤0.01%
205
-3
-1% -$195
LFCR icon
1921
Lifecore Biomedical
LFCR
$165M
$15K ﹤0.01%
2,416
STBA icon
1922
S&T Bancorp
STBA
$1.92B
$14.9K ﹤0.01%
447
KD icon
1923
Kyndryl
KD
$2.94B
$14.9K ﹤0.01%
717
+178
+33% +$3.04K
MCRI icon
1924
Monarch Casino & Resort
MCRI
$2.2B
$14.7K ﹤0.01%
213
-181
-46% -$11.5K
SKIN icon
1925
SkinHealth Systems
SKIN
$90.5M
$14.7K ﹤0.01%
4,728
+4,539
+2,402% +$17K

Similar funds

Quadrant Capital Group's Q4 2023 Portfolio in Review

As of Q4 2023, Quadrant Capital Group held 2,827 positions worth $1.16B, up 17% from $999M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Quadrant Capital Group deployed $61M of net new capital in Q4 2023, opening 142 new positions and adding to 1,379 existing holdings. Its largest new stake was Fidelity Total Bond ETF: 106,946 shares worth $4.92M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $3.96M trimmed.

  • Quadrant Capital Group's largest Q4 2023 buy was Fidelity Total Bond ETF: 106,946 shares worth $4.92M.
  • Quadrant Capital Group added most to JPMorgan Ultra-Short Income ETF in Q4 2023, an estimated $13.1M increase.
  • Quadrant Capital Group's biggest Q4 2023 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $3.96M.
  • Quadrant Capital Group fully exited Activision Blizzard in Q4 2023, selling an estimated $967K.
  • Quadrant Capital Group's ten largest holdings make up 34% of its $1.16B portfolio in Q4 2023.
  • Quadrant Capital Group opened 142 new positions and closed 136 in Q4 2023.
  • Quadrant Capital Group's portfolio value rose 17% quarter-over-quarter to $1.16B.

Based on Quadrant Capital Group's 13F filing for Q4 2023, filed 8 Feb 2024.